Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Sv Health Investors LLP

BioCentury | Jan 5, 2024
Management Tracks

Friedman succeeding Hoos at Scorpion

Plus: 4DMT hires Noriyuki Kasahara as CSO, and updates from SV, Omega, AbbVie Ventures, Nikang, Immunome, Wugen, Zevra and Quris
BioCentury | Aug 30, 2018
Targets & Mechanisms

Alt-neoantigens

Two studies tap a new vein of cancer neoantigens via alternative splicing
BioCentury | May 17, 2018
Finance

Europe’s piece of the pie

Where European life science innovators can take the lead
BioCentury | Jan 17, 2018
Financial News

SV Health announces promotions

BioCentury | Dec 15, 2017
Financial News

Pionyr raises $62M series B

Items per page:
1 - 10 of 14